Bionano Genomics Optical Genome Mapping
Bionano Genomics, Inc. (Nasdaq: BNGO) has started a preclinical evaluation study using optical genome mapping. The Saphyr system will be used as a research tool to analyze the genomes of couples who have experienced recurrent pregnancy loss or recurrent embryo implantation failure. The study’s objective is to determine whether the improved resolution of OGM, compared …